Selection of mesenchymal-like metastatic cells in primary tumors - an in silico investigation

Frontiers in Immunology

Volumn 3, Issue APR, 2012, Pages

  Narang, Vipin ^a   Wong, Shek Yoon ^a   Leong, Shiang Rong ^a   Harish, Bindu ^a   Abastado, Jean Pierre ^a   Gouaillard, Alexandre ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

Agent based modeling and simulation; Epithelial to mesenchymal transition; Tumor microenvironment

Indexed keywords

EID: 84874182055     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00088     Document Type: Article

References (37)

1. Bacac, M., and Stamenkovic, I. (2008). Metastatic cancer cell. Annu. Rev. Pathol. 3, 221-247.
2. Bonabeau,E. (2002). Agent-based modeling: methods and techniques for simulating human systems. Proc. Natl. Acad. Sci. U.S.A. 99(Suppl. 3), 7280-7287.
3. Bonde, A. K., Tischler, V., Kumar, S., Soltermann, A., and Schwendener, R. (2012). Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer 12, 35. doi:10.1186/1471-2407-12-35
4. Brent, R., and Bruck, J. (2006). 2020 computing: can computers help to explain biology? Nature 440, 416-417.
5. Casciari, J. J., Sotirchos, S. V., and Sutherland, R. M. (1992). Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J. Cell. Physiol. 151, 386-394.
6. Drasdo, D., and Hoehme, S. (2005). A single-cell-based model of tumor growth in vitro: monolayers and spheroids. Phys. Biol. 2, 133-147.
7. Duffey, B. G., Choyke, P. L., Glenn, G., Grubb,R. L.,Venzon,D.,Linehan,W. M., and Walther, M. M. (2004). The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J. Urol. 172, 63-65.
8. Ebos, J. M., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., and Kerbel, R. S. (2009). Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232-239.
9. Eyles, J., Puaux, A.-L., Wang, X., Toh, B., Prakash, C., Hong, M., Tan, T. G., Zheng, L., Ong, L. C., Jin, Y., Kato, M., Prévost-Blondel, A., Chow, P., Yang, H., and Abastado, J.-P. (2010). Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest. 120, 2030-2039.
10. Fasani, P., Sangiovanni, A., De Fazio, C., Borzio, M., Bruno, S., Ronchi, G., Del Ninno, E., and Colombo, M. (1999). High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology 29, 1704-1707.
11. Ferreira,S. C.,Martins,M. L.,and Vilela, M. J. (2002). Reaction-diffusion model for the growth of avascular tumor. Phys.Rev.E65, 021907.
12. Fidler, I. J., and Kripke, M. L. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893-895.
13. Gatenby, R. A., and Gillies, R. J. (2008). A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 8, 56-61.
14. Gavert, N., and Ben-Ze'ev, A. (2010). Coordinating changes in cell adhesion and phenotype during EMT like processes in cancer. F1000 Biol. Rep. 2, 86.
15. Giordano, S. H., Buzdar, A. U., Smith, T. L., Kau, S. W., Yang, Y., and Hortobagyi, G. N. (2004). Is breast cancer survival improving? Cancer 100, 44-52.
16. Gonzalez-Garcia, I., Sole, R. V., and Costa, J. (2002). Metapopulation dynamics and spatial heterogeneity in cancer. Proc. Natl.Acad. Sci. U.S.A. 99, 13085-13089.
17. Grimm, V., and Railsback, S. F. (2005). Individual-Based Modeling and Ecology. New Jersey: Princeton University Press.
18. Haile, J. M. (1992). Molecular Dynamics Simulation: Elementary Methods. New York: John Wiley and Sons.
19. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
20. Husemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T., Riethmuller, G., and Klein, C. A. (2008). Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68.
21. Jeon, J., Quaranta, V., and Cummings, P. T. (2010). An off-lattice hybrid discrete-continuum model of tumor growth and invasion. Biophys. J. 98, 37-47.
22. Kalluri, R. (2009). EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119, 1417-1419.
23. Kalluri, R., and Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428.
24. Kohl, P., Noble, D., Winslow, R. L., and Hunter, P. J. (2000). Computational modelling of biological systems: tools and visions. Philos. Trans. R. Soc. Lond. A 358, 579-610.
25. Kumar, A. (2001). A discretization of the n-dimensional Laplacian for a dimension-independent stability limit. Proc. R. Soc. Lond. A 457, 2667-2674.
26. Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., Risques, R. A., Rabinovitch, P. S., and Reid, B. J. (2006). Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38, 468-473.
27. Mallet, D. G., and Pillis, L. G. D. (2006). A cellular automata model of tumor-immune system interactions. J. Theor. Biol. 239, 334-350.
28. Mehrara, E., Forssell-Aronsson, E., Ahlman, H., and Bernhardt, P. (2009). Quantitative analysis of tumor growth rate and changes in tumor marker level: specific growth rate versus doubling time. Acta Oncol. 48, 591-597.
29. Merlo, L. M., Pepper, J. W., Reid, B. J., and Maley,C. C. (2006). Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935.
30. Noble, D. (2008). Computational models of the heart and their use in assessing the actions of drugs. J. Pharmacol. Sci. 107, 107-117.
31. Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Vinals, F., Inoue, M., Bergers, G., Hanahan, D., and Casanovas, O. (2009). Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220-231.
32. Polyak, K., Haviv, I., and Campbell, I. G. (2009). Co-evolution of tumor cells and their microenvironment. Trends Genet. 25, 30-38.
33. Rejniak, K. A., and Anderson, A. R. A. (2010). Hybrid models of tumor growth. Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 115-125.
34. Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., Haluska, P., Ingle, J. N., Hartmann, L. C., Manjili, M. H., Radisky,D. C.,Ferrone,S.,and Knutson, K. L. (2009). Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res. 69, 2887-2895.
35. Song, B. C., Chung, Y. H., Kim, J. A., Lee, H. C., Yoon, H. K., Sung, K. B., Yang, S. H., Yoo, K., Lee, Y. S., and Suh, D. J. (2001). Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study. Cancer 91, 2386-2393.
36. Strumane, K., Berx, G., and Roy, F. (2004). "Cadherins in cancer," in Handbook of Experimental Pharmacology,Vol. 165,eds J. Behrens andW. J. Nelson (Berlin: Springer-Verlag), 69-103.
37. Toh, B., Wang, X., Keeble, J., Sim, W. J., Khoo, K., Wong, W.-C., Kato, M., Prevost-Blondel,A.,Thiery,J.-P.,and Abastado, J.-P. (2011). Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol. 9, e1001162. doi:10.1371/journal.pbio.1001162